|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/29 | |
| C12P 21/06 | |||
| C07H 21/02 |
| (11) | Number of the document | 1874346 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06751075.0 |
| Date of filing the European patent application | 2006-04-24 | |
| (97) | Date of publication of the European application | 2008-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/015241 |
| Date | 2006-04-24 |
| (87) | Number | WO 2006/116182 |
| Date | 2006-11-02 |
| (30) | Number | Date | Country code |
| 674415 P | 2005-04-24 | US | |
| 674546 P | 2005-04-25 | US |
| (72) |
PUGACHEV, Konstantin V., US
GUIRAKHOO, Farshad, US
MONATH, Thomas P., US
|
| (73) |
Sanofi Pasteur Biologics, LLC,
38 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | RECOMBINANT FLAVIVIRUS VACCINES |
| RECOMBINANT FLAVIVIRUS VACCINES |